Informações:
Falhas:
ID
33921
Descrição
Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif; ODM derived from: https://clinicaltrials.gov/show/NCT02377323
Link
https://clinicaltrials.gov/show/NCT02377323
Palavras-chave
Versões (1)
- 07/01/2019 07/01/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
7 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Multiple Sclerosis NCT02377323
Eligibility Multiple Sclerosis NCT02377323
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT02377323
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Clinically isolated syndrome | Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive
Item
patients with cis or definite ms (rrms or spms);
boolean
C2921627 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
C0751967 (UMLS CUI [3])
C0751965 (UMLS CUI [4])
C0026769 (UMLS CUI [2])
C0751967 (UMLS CUI [3])
C0751965 (UMLS CUI [4])
Clinic Visit
Item
patients seen at our clinic within the last 2 years;
boolean
C0008952 (UMLS CUI [1])
Patients Untreated | Rebif Low dose | Rebif High dose
Item
patients untreated, or treated with either low dose or high dose rebif for at least two years;
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0752980 (UMLS CUI [2,1])
C0445550 (UMLS CUI [2,2])
C0752980 (UMLS CUI [3,1])
C0444956 (UMLS CUI [3,2])
C0332155 (UMLS CUI [1,2])
C0752980 (UMLS CUI [2,1])
C0445550 (UMLS CUI [2,2])
C0752980 (UMLS CUI [3,1])
C0444956 (UMLS CUI [3,2])
Age
Item
patients between 18 to 60 years old at time of treatment initiation;
boolean
C0001779 (UMLS CUI [1])
EDSS
Item
edss ≤ 5.5 at treatment initiation;
boolean
C0451246 (UMLS CUI [1])
Able to read French language | Able to write French language
Item
patients able to read and write in french.
boolean
C0586740 (UMLS CUI [1,1])
C0376246 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376246 (UMLS CUI [2,2])
C0376246 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376246 (UMLS CUI [2,2])
Multiple Sclerosis, Primary Progressive
Item
patients diagnosed with primary progressive ms;
boolean
C0751964 (UMLS CUI [1])
Disease Modification Pharmaceutical Preparations | Exception Rebif
Item
patients treated with other dmd, other than rebif;
boolean
C0012634 (UMLS CUI [1,1])
C3840684 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0752980 (UMLS CUI [2,2])
C3840684 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0752980 (UMLS CUI [2,2])
Comorbidity Influence Research results
Item
co-existence of other diseases that could influence outcomes.
boolean
C0009488 (UMLS CUI [1,1])
C4054723 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C4054723 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])